APA (7th ed.) Citation

Houles, T., Boucher, J., Lavoie, G., MacLeod, G., Lin, S., Angers, S., & Roux, P. P. (2023). The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes cyclin K degradation in melanoma. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Houles, Thibault, Jonathan Boucher, Geneviève Lavoie, Graham MacLeod, Sichun Lin, Stephane Angers, and Philippe P. Roux. The CDK12 Inhibitor SR-4835 Functions as a Molecular Glue That Promotes Cyclin K Degradation in Melanoma. Nature Publishing Group, 2023.

MLA (9th ed.) Citation

Houles, Thibault, et al. The CDK12 Inhibitor SR-4835 Functions as a Molecular Glue That Promotes Cyclin K Degradation in Melanoma. Nature Publishing Group, 2023.